News und Analysen
DGAP-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
DGAP-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
DGAP-News: BB BIOTECH AG: Political factors weigh on biotech equity markets
DGAP-News: BB BIOTECH AG: Political factors weigh on biotech equity markets
DGAP-News: BB BIOTECH AG: Politische Faktoren beeinflussen Biotechaktienmärkte
DGAP-News: BB BIOTECH AG: Politische Faktoren beeinflussen Biotechaktienmärkte
DGAP-News: MorphoSys und I-Mab Biopharma Verkünden Freigabe für MOR202/TJ202 zum Beginn Klinischer Studien beim Multiplen Myelom in China
DGAP-News: MorphoSys und I-Mab Biopharma Verkünden Freigabe für MOR202/TJ202 zum Beginn Klinischer Studien beim Multiplen Myelom in China
DGAP-News: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China
DGAP-News: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China
DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS UNTERZEICHNEN LIZENZVEREINBARUNG FÜR EIN BIOSIMILAR-PROGRAMM
DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS UNTERZEICHNEN LIZENZVEREINBARUNG FÜR EIN BIOSIMILAR-PROGRAMM
DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET
DGAP-News: JUST - EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
DGAP-News: EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION
DGAP-News: EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION
DGAP-News: EVOTEC UND CELMATIX GEHEN STRATEGISCHE ZUSAMMENARBEIT EIN
DGAP-News: EVOTEC UND CELMATIX GEHEN STRATEGISCHE ZUSAMMENARBEIT EIN
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces CEO leadership transition
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces CEO leadership transition
DGAP-Adhoc: QIAGEN N.V.: QIAGEN gibt CEO Führungswechsel bekannt
DGAP-Adhoc: QIAGEN N.V.: QIAGEN gibt CEO Führungswechsel bekannt
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces deviation from preliminary sales result expectations for the third quarter of 2019
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces deviation from preliminary sales result expectations for the third quarter of 2019
DGAP-Adhoc: QIAGEN N.V.: QIAGEN gibt Abweichung von den vorläufigen Umsatzzahlen für das dritte Quartal 2019 bekannt
DGAP-Adhoc: QIAGEN N.V.: QIAGEN gibt Abweichung von den vorläufigen Umsatzzahlen für das dritte Quartal 2019 bekannt
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces measures to prioritize resource allocation in its Sample to Insight Portfolio
DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces measures to prioritize resource allocation in its Sample to Insight Portfolio
DGAP-Adhoc: QIAGEN N.V.: QIAGEN kündigt Maßnahmen zur Priorisierung von Ressourcen für das 'Sample to Insight' Portfolio an
DGAP-Adhoc: QIAGEN N.V.: QIAGEN kündigt Maßnahmen zur Priorisierung von Ressourcen für das 'Sample to Insight' Portfolio an
Why Integra Lifesciences Stock Is Sinking Today
Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the
Why Arm Holdings Stock Is Jumping Today
Arm Holdings (NASDAQ: ARM) stock is advancing in Tuesday's trading. The semiconductor company's share price was up 5% as of 3 p.m. ET, according to data from S&P Global Market Intelligence.
While
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
EQS-News: MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
EQS-News: MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
EQS-Adhoc: Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQS-Adhoc: Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer remains on track in 1st half year 2024
Why Lantheus Holdings Stock Is Skyrocketing Today
Shares of Lantheus Holdings (NASDAQ: LNTH) were skyrocketing on Wednesday, up 34% as of 11:20 a.m. ET. The big gain came after the Centers for Medicare and Medicaid Services (CMS) released a